This inventor holds 2 USPTO granted patents. Top assignee: Nps Allelix Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Sally-Lin Adams
Introduction
Sally-Lin Adams is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of neuroscience through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the modulation of neurotransmission by excitatory amino acids.
Latest Patents
Adams' latest patents include groundbreaking inventions related to neurotransmission. The first patent, titled "Human NR2A binding assay," describes how neurotransmission by excitatory amino acids, such as glutamate, is mediated via membrane-bound surface receptors. This neurotransmission is modulated by specific proteins, which Adams has isolated and characterized. The patent details recombinant cell lines that produce these modulatory proteins as heterologous membrane-bound products. Additionally, it discusses the commercial significance of using these cell lines to discover compounds that affect the function of the modulatory proteins.
The second patent, "Ionotropic human glutamate receptor subunit NR3," also addresses the modulation of neurotransmission by excitatory amino acids. Similar to her first patent, it describes the isolation and characterization of modulatory proteins and the development of recombinant cell lines. This invention further emphasizes the potential for commercial applications in discovering compounds that influence the function of these proteins.
Career Highlights
Sally-Lin Adams has established herself as a key figure in her field through her work at NPS Allelix Corporation. Her research has not only advanced scientific understanding but has also opened new avenues for therapeutic development.
Collaborations
Throughout her career, Adams has collaborated with notable colleagues, including Robert Foldes and Rajender Kamboj. These partnerships have contributed to the success and impact of her research.
Conclusion
Sally-Lin Adams is a trailblazer in the field of neuroscience, with her innovative patents paving the way for future discoveries. Her contributions to understanding neurotransmission and the development of related technologies highlight her importance as an inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile